Literature DB >> 1595537

Atrioventricular block during adenosine thallium imaging.

J Lee1, J Heo, J D Ogilby, V Cave, B Iskandrian, A S Iskandrian.   

Abstract

Transient atrioventricular (AV) block has been reported during adenosine thallium imaging. This study examined the predictors and hemodynamic implications in 55 patients who had second- or third-degree AV block (group 1) and compared the results with those in 803 patients who did not have AV block (group 2). There were no significant differences in age, sex, or heart rate at baseline between the two groups. ST segment depression was observed in 25% of patients in group 1 and 16% in group 2 (p = NS). Chest pain occurred in 56% in group 1 and 44% in group 2 (p = NS). Preexisting conduction abnormalities (17% vs 16%) and treatment with digitalis (15% vs 15%) and beta-blockers (31% vs 36%) were similar in the two groups. The results of thallium imaging were abnormal in 66% in group 1 and 67% in group 2 (p = NS). Reversible thallium defects were seen in 51% in group 1 and 52% in group 2 (p = NS). The AV block appeared during the first 2 minutes of infusion in 40 patients (73%) and disappeared despite continuation of infusion in 43 (78%). The heart rate during AV block was 79 +/- 18 beats/min, and the systolic blood pressure was 127 +/- 27 mm Hg. Premature termination of adenosine infusion was required in one patient (2%). Aminophylline was used in 5% in group 1 and 2% in group 2 (p = NS). Thus AV block is transient, occurs during the early minutes of infusion, is not aggravated by digitalis or beta-blocker therapy, can be seen in patients with normal perfusion images, and is often well tolerated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595537     DOI: 10.1016/0002-8703(92)90811-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

1.  Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.

Authors:  Hsiao D Lieu; John C Shryock; Gregory O von Mering; Toufigh Gordi; Brent Blackburn; Ann W Olmsted; Luiz Belardinelli; Richard A Kerensky
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 2.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

3.  Imaging guidelines for nuclear cardiology procedures. American Society of Nuclear Cardiology. Myocardial perfusion stress protocols.

Authors: 
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

4.  Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease.

Authors:  Theodoros D Karamitsos; Jayanth R Arnold; Tammy J Pegg; Adrian S H Cheng; William J van Gaal; Jane M Francis; Adrian P Banning; Stefan Neubauer; Joseph B Selvanayagam
Journal:  Int J Cardiovasc Imaging       Date:  2008-11-27       Impact factor: 2.357

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.